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Introduction
AKI is currently defined by changes in Creatinine and
urine output, but both parameters have limitations in
critically ill patients. We have previously validated a
method of measuring GFR using a continuous infusion
of low dose Iohexol (CILDI) in patients with stable renal
function and calculate that variations >10.3% depicts
AKI (p = 0.003). All subjects reached steady state within
10h. In this study we measure the performance of
CILDI in patients with different risks of AKI.
AIM. Validate CILDI as a measure of GFR during AKI.
Methods
11 patients post nephrectomy [NEPH; predictable onset,
predicted 50% drop in GFR], 11 patients post vascular sur-
gery [VASC; predicted onset of AKI, unpredictable out-
come], and 13 patients with established AKI [AKI;
unpredictable onset and outcome] were recruited. CILDI
was applied at 0.5mL/h for 24-84h. Urine and serum
Iohexol concentrations were measured by tandem mass
spectrometry. Accuracy of CILDI was determined by com-
paring the mean GFR drop in the NEPH group with the
predicted 50% change, and by comparing plasma clearance
(PC) with renal clearance (RC). Precision was confirmed
by measuring the co-efficient of variation (CV) of repeated
measurements taken in 2h periods.
Results
Mean APACHE score was 11 ± 4 (NEPH), 13 ± 2 (VASC)
and 18 ± 5 (AKI; p = 0.0004). There was no difference in
baseline eGFR (p = 0.70). Mean GFR at 10-14h was 51.4 ±
18.3% of baseline (NEPH), 52 ± 29% baseline (VASC) and
44 ± 31% (AKI group). There was no difference between
the predicted drop of 50% and measured drop in the
NEPH group (p = 0.81), confirming accuracy of CILDI.
Correlation between PC and RC was good: 0.73 (NEPH),
0.82 (VASC) and 0.92 (AKI). The diagnosis of AKI would
have been missed in 5 NEPH patients and 4 VASC
patients using conventional criteria. In addition, 2 patients
who had AKI defined by creatinine, did not have AKI
when measured by CILDI. CV was 3.4% overall and small
in each group: 3.6% (NEPH), 2.5% (VASC) and 2.1% (AKI).
Conclusions
CILDI appears to be accurate and precise in measuring
changing GFR in patients with AKI. We hypothesise
that if our findings are externally validated, then new
definition of AKI should incorporate changes in GFR
measured by CILDI. CILDI is now ready to be used in
studies measuring the effects of AKI.
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